IL132933A0 - Composition for the treatment of diarrheal disease - Google Patents

Composition for the treatment of diarrheal disease

Info

Publication number
IL132933A0
IL132933A0 IL13293398A IL13293398A IL132933A0 IL 132933 A0 IL132933 A0 IL 132933A0 IL 13293398 A IL13293398 A IL 13293398A IL 13293398 A IL13293398 A IL 13293398A IL 132933 A0 IL132933 A0 IL 132933A0
Authority
IL
Israel
Prior art keywords
treatment
composition
diarrheal disease
methods
lanthocins
Prior art date
Application number
IL13293398A
Other languages
English (en)
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of IL132933A0 publication Critical patent/IL132933A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL13293398A 1997-06-09 1998-06-08 Composition for the treatment of diarrheal disease IL132933A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4923697P 1997-06-09 1997-06-09
US08/950,225 US5985823A (en) 1997-06-09 1997-10-14 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
PCT/US1998/011820 WO1998056398A2 (en) 1997-06-09 1998-06-08 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon

Publications (1)

Publication Number Publication Date
IL132933A0 true IL132933A0 (en) 2001-03-19

Family

ID=26726981

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13293398A IL132933A0 (en) 1997-06-09 1998-06-08 Composition for the treatment of diarrheal disease

Country Status (16)

Country Link
US (1) US5985823A (de)
EP (1) EP0983079B1 (de)
JP (1) JP2002504906A (de)
CN (1) CN1264306A (de)
AT (1) ATE289821T1 (de)
AU (1) AU7826298A (de)
BR (1) BR9810861A (de)
CA (1) CA2291645A1 (de)
DE (1) DE69829179T2 (de)
IL (1) IL132933A0 (de)
NO (1) NO996035L (de)
PL (1) PL337779A1 (de)
PT (1) PT983079E (de)
SK (1) SK169499A3 (de)
TW (1) TW505515B (de)
WO (1) WO1998056398A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete
EA200500804A1 (ru) * 2002-12-10 2005-12-29 Биосинексус Инкорпорейтед Топические противоинфекционные композиции
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
ITMI20041295A1 (it) 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
US20100003235A1 (en) * 2005-09-28 2010-01-07 Hagie Frank E Oral formulations for enteric disorders and/or rehydration
GB0600928D0 (en) * 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
JP2009526069A (ja) * 2006-02-08 2009-07-16 バイオシネクサス インコーポレーティッド 細菌胞子の中和
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
US20100239682A1 (en) * 2007-09-17 2010-09-23 Antoine Andremont Colonic delivery of antimicrobial agents
CA2749278A1 (en) * 2009-01-14 2010-07-22 Novacta Biosystems Limited Deoxyactagardine derivatives
CN102388060B (zh) 2009-02-04 2014-09-10 诺瓦克塔生物系统有限公司 阿肽加定衍生物
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
EA201291461A1 (ru) 2010-07-14 2013-08-30 Новакта Биосистемс Лимитед Состав, содержащий лантибиотик типа b
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
CA2903499A1 (en) * 2013-03-14 2014-10-02 Avidbiotics Corp. Diffocins and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins
NZ311535A (en) * 1995-06-23 2001-05-25 Ambi Inc A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection

Also Published As

Publication number Publication date
JP2002504906A (ja) 2002-02-12
WO1998056398A2 (en) 1998-12-17
DE69829179T2 (de) 2005-07-21
NO996035D0 (no) 1999-12-08
SK169499A3 (en) 2001-03-12
DE69829179D1 (de) 2005-04-07
CN1264306A (zh) 2000-08-23
EP0983079B1 (de) 2005-03-02
PT983079E (pt) 2005-06-30
AU7826298A (en) 1998-12-30
BR9810861A (pt) 2001-04-24
TW505515B (en) 2002-10-11
NO996035L (no) 1999-12-08
ATE289821T1 (de) 2005-03-15
EP0983079A2 (de) 2000-03-08
US5985823A (en) 1999-11-16
WO1998056398A3 (en) 1999-03-25
PL337779A1 (en) 2000-09-11
CA2291645A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
IL132933A0 (en) Composition for the treatment of diarrheal disease
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
NZ324500A (en) Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
AP9200410A0 (en) Retroviral protease inhibitors.
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
UA48940C2 (uk) Рекомбінатні il4 антитіла, які використовуються для лікування il4-опосередкованих порушень
GB9515279D0 (en) Improved therapeutic agents
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
CY2225B1 (en) Organic compounds
EA200100140A1 (ru) Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами
DE69330268D1 (de) Hämoregulierende peptide
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
BR9611520A (pt) Composto hemo-reguladores.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
AR010723A1 (es) COMPOSICIoN PARA EL TRATAMIENTO DE ENFERMEDADES ESTRoGENOS DEPENDIENTES, POR INHIBIR EL COMPLEJO ENZIMÁTICO AROMATASA, CARACTERIZADAS POR CONTENER LACTONAS SESQUITERPÉNICAS SINTÉTICAS, SEMISINTÉTICAS Y NATURALES (EXCEPTO DEHIDROLEUCODINA, LUDARTINA Y HELENALINA)
UA29770A (uk) Спосіб пригнічення репродукції вірусу імунодефіциту людини